Sundaram Vinay, Manne Vignan, Al-Osaimi Abdullah M S
Department of Medicine, Division of Hepatology, Temple University Health System, Philadelphia, Pennsylvania, USA.
Saudi J Gastroenterol. 2014 Sep-Oct;20(5):279-87. doi: 10.4103/1319-3767.141686.
Cirrhosis affects millions of people throughout the world. Two of the most serious complications of liver cirrhosis are ascites and spontaneous bacterial peritonitis (SBP). The development of ascites is related to the severity of portal hypertension and is an indicator of increased mortality. Although sodium restriction and diuretic therapy have proven effective, some patients may not respond appropriately or develop adverse reactions to diuretic therapy. In such cases, interventions such as transjugular intrahepatic portosystemic shunt (TIPS) placement are warranted. SBP is a complication of ascites that confers a very high mortality rate. Recognition and prompt treatment of this condition is essential to prevent serious morbidity and mortality. Initiation of prophylaxis in SBP remains controversial. Given the burden of liver cirrhosis on the health care system, ascites and SBP will continue to provide challenges for the primary care provider, hospitalist, internist, and gastroenterologist alike.
肝硬化影响着全球数百万人。肝硬化最严重的两种并发症是腹水和自发性细菌性腹膜炎(SBP)。腹水的形成与门静脉高压的严重程度有关,是死亡率增加的一个指标。尽管限制钠摄入和利尿治疗已被证明有效,但一些患者可能对利尿治疗反应不佳或出现不良反应。在这种情况下,诸如经颈静脉肝内门体分流术(TIPS)植入等干预措施是必要的。SBP是腹水的一种并发症,死亡率非常高。识别并及时治疗这种疾病对于预防严重的发病率和死亡率至关重要。SBP预防性治疗的启动仍存在争议。鉴于肝硬化给医疗保健系统带来的负担,腹水和SBP将继续给初级保健提供者、住院医师、内科医生和胃肠病学家带来挑战。